Načítá se...
Anti- c-myc cholesterol based lipoplexes as onco-nanotherapeutic agents in vitro
Background: Strategies aimed at inhibiting the expression of the c-myc oncogene could provide the basis for alternative cancer treatment. In this regard, silencing c-myc expression using small interfering RNA (siRNA) is an attractive option. However, the development of a clinically viable, siRNA-bas...
Uloženo v:
| Vydáno v: | F1000Res |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
F1000 Research Limited
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7745184/ https://ncbi.nlm.nih.gov/pubmed/33391729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.25142.2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|